Side effects of stress echocardiography with dobutamine;EFECTOS SECUNDARIOS DE LA ECOCARDIOGRAFIA DE ESTRES CON DOBUTAMINA

Revista Espanola de Cardiologia

Volumn 49, Issue 1, 1996, Pages 22-28

  Cladellas Capdevila, Mercè ^a   Bruguera Cortada, Jordi ^a   Hernández Herrero, Juan ^a   Villena Segura, Josefa ^a   Serrat Serradell, Ramón ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

dobutamine; stress echocardiography

Indexed keywords

ATROPINE; DOBUTAMINE; CARDIOTONIC AGENT; DIAGNOSTIC AGENT;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART ARRHYTHMIA; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; SUPRAVENTRICULAR TACHYCARDIA; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; METHODOLOGY; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDY; RISK FACTOR; SURGERY; TIME;

ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ARRHYTHMIA; CARDIOTONIC AGENTS; DOBUTAMINE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE; TIME FACTORS;

EID: 0029949864     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Picano E. Stress echocardiography. Berlín: Springer-Verlag, 1992.
2. Bach DS, Armstrong WF. Dobutamine stress echocardiography. Am J Cardiol 1992; 69: 90H-96H.
3. Mazeika P, Nihoyannpoulos P, Oakley CM. Stress echocardiography: time for critical reappraisal. Br Heart J 1993; 70: 208-210.
4. San Román JA, Vilacosta I, Castillo JA, Rollán MJ, Sánchez-Harguindey L. Comparación de la ecocardiografía con administración de dobutamina y la prueba de esfuerzo en la detección de enfermedad coronaria. Rev Esp Cardiol 1994; 47: 221-226.
5. Sawada SG, Segar S, Ryan, Brown SE. Dohan AM, Williams R et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991; 83: 1.605-1.614.
6. Marcovitz PA, Armstrong WF. Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. Am J Cardiol 1992; 69: 1.273-1.289.
7. Cohen JL, Greene TO, Ottenweller J, Binenbaum SZ, Wilchfort SD, Kim CS. Dobutamine digital echocardiography for detecting coronary artery disease. Am J Cardiol 1991; 67: 1.311-1.318.
8. Berthe D, Pierard LA, Hiernaux M, Trotteur G, Lempereur P, Carlier J et al. Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion. Am J Cardiol 1986; 58: 1.167-1.172.
9. Previtali M, Poli A, Lanzari L, Fetiveau R, Mussini A, Ferrario M. Dobutamine stress echocardiography for assessment of myocardial viability and ischemia in acute myocardial infarction treated with thrombolysis. Am J Cardiol 1993; 72: 124G-130G.
10. Smart SC, Sawada S, Ryan T, Segar D, Atherton L, Berkovitz K et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993; 88: 405-415.
11. Cladellas M, Bruguera J, Vidal-Barraquer F, Castillo J, Parés N. Ecocardiografía de estrés con dobutamina en la valoración del riesgo quirúrgico en pacientes de cirugía vascular. Rev Esp Cardiol 1994; 47 (Supl 2): 11.
12. Lane RT, Sawada SG, Segar DS, Ryan T, Lalka SG, Williams R et al. Dobutamine stress echocardiography for assessment of cardiac risk before noncardiac surgery. Am J Cardiol 1991; 68. 976-977.
13. Poldermans D, Fioretti PM, Boersma E, Forster T, Urk HV, Cornel JH et al. Safety of Dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. Am J Cardiol 1994; 73: 456-459.
14. Picano E, Mathias W, Pingitore A, Bigi R, Previtali M, and Echo Dobutamine International Cooperative Study Group. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentric study. Lancet 1994; 344: 1.190-1.192.
15. Coma-Canella I, Gómez MV, González A, Gallardo F1 Oliver J, Castro JM. Detección de isquemia en angina estable. Valor comparative de la ventriculografía isotópica, ecocardiograma y tomografía con talio. Rev Esp Cardiol 1994; 47 (Supl 2): 57.
16. Castillo J, Vilacosta I, San Roman JA, Rollán MJ, Almería C, Alonso L et al. Diagnóstico de enfermedad coronaria mediante eco-dobutamina en pacientes hipertensos: comparación con la prueba de esfuerzo. Rev Esp Cardiol 1994; 47 (Supl 2): 59.
17. Sanchís J, Muñoz J, Chorro FJ, Insa L, Merino J, Llopis R et al. Utilidad del ecocardiograma de stress con dobutamina en la identificación del miocardio aturdido posttrombolisis. Rev Esp Cardiol 1993; 46 (Supl 1): 37.
18. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-367.
19. Cladellas M, Bruguera J. Diagnóstic de l'ecocardiografia d'estrès amb dobutamina en malalts amb o sense tractament betabloquejant. Ann Med (Bare) 1980; 4: 26.
20. Mertes H, Sawada SG, Ryan T, Segar DS, Kovacs R, Foltz J et al. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Circulation 1993; 88: 15-19.
21. Marwick T, D'Hondt AM, Baudhuin T, Willemart B, Wijns W, Detry JM et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol 1993; 22: 159-167.
22. Marcovitz PA, Bach DS, Mathias W, Shayna V, Armstrong WF. Paradoxic hypotension during dobutamine stress echocardiography: clinical and diagnostic implications. J Am Coll Cardiol 1993; 21: 1.080-1.086.
23. Mazeika PK, Nadazdin A, Oakley CM. Clinical significance of abrupt vasodepression during dobutamine stress echocardiography. Am J Cardiol 1992; 69: 1.484-1.486.
24. Pellika PA, Oh JK, Bailey KR, Nichols BA, Monohan KH, Tajik AJ. Dynamic intraventricular obstruction during dobutamine stress echocardiography. Circulation 1992; 86: 1.429-1.432.
25. Castillo JA, Vilacosta I, San Roman JA, Rollán MJ, Almería C, Alonso L et al. Incidencia e implicaciones de la obstrucción al tracto de salida del ventrículo izquierdo durante la ecodobutamina. Rev Esp Cardiol 1994; 47 (Supl 2): 22.
26. Mintz GS, Kotler MN, Segal BL, Parry WR. Systolic anterior motion of the mitral valve in the absence of asymmetric septal hypertrophy. Circulation 1978; 57: 256-263.
27. Rude RE, Izquierdo C, Buja LM, Willerson JT. Effects of inotropic and chronotropic stimuli on acute myocardial ischemi injury. Circulation 1982; 65: 1.321-1.328.
28. Cohen JL, Ottenweller JE, George AK, Duvvuri S. Comparison of dobutamine and exercise echocardiography for detecting coronary artery disease. Am J Cardiol 1993; 72: 1.226-1.231.
29. Herman SD, Kenneth A, LaBresh KA, Santos-Ocampo CD, Garber CE, Barbour MM et al. Comparison of Dobutamine and exercise using technetium-99m sestamibi imaging for the evaluation of coronary artery disease. Am J Cardiol 1994; 73: 164-169.
30. McNeill AJ, Fioretti PM, El-Said EM, Salustri A, Forster T, Roeliandt JRTC. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 1992; 70: 41-46.
31. a ed). Londres: The Pharmaceutical Press, 1993; 1.242-1.243.
32. Adams RG, Verma P, Jackson AJ, Miller RL. Plasma pharmacokinetics of intravenously administered atropine in normal human subjects. J Clin Pharmacol 1982; 22: 477-481.
33. San Román JA, Vilacosta I, Castillo JA, Rollán MJ, Sánchez-Harguindey L. Implicaciones del tratamiento con betabloqueantes en la ecocardiografía con dobutamina. Rev Esp Cardiol 1993; 46 (Supl 1): 45.